Association of Certain Gene Polymorphisms with the Risk of Atrial Fibrillation in Patients with Ischemic Heart Disease
Keywords:
atrial fibrillation, genetic study, renin-angiotensin system, human angiotensinogenAbstract
There is increasing evidence that gene-environment interactions play an important role in genetic studies of complex diseases. The renin-angiotensin system is a major regulator of blood pressure and cardiovascular homeostasis. AGT is an important component of the renin-angiotensin system. AGT is a precursor of angiotensin II, which causes acute vasoconstriction and stimulates proliferation of vascular muscle cells and cardiomyocytes. Many studies have evaluated the association of AGT T174M polymorphism with CHD risk, but the above observed associations consisted of a small number of samples, and the results may reflect chance observations rather than true associations.
References
Kadyrova F. et al. Поширенiсть бессимптомно гiперурикемii серед хворих з iшемiчною хворобою //Здобутки клінічної і експериментальної медицини. – 2017. – №. 2.
Насырова З. А., Абдуллоева М. Д., Усаров Ш. А. У. СТРАТИФИКАЦИЯ ФАКТОРОВ РИСКА ПРИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА //Journal of cardiorespiratory research. – 2021. – Т. 1. – №. 3. – С. 14-17.
Ташкенбаева Э. Н., Насырова З. А., Тоиров А. Э. Течение нестабильных вариантов стенокардии при полиморбидных состояниях //Colloquium-journal. – Голопристанський міськрайонний центр зайнятості= Голопристанский районный центр занятости, 2019. – №. 27-3. – С. 45-49.
Элламонов С. Н. и др. Факторы прогрессирования артериальной гипертензии у больных в коморбидности с сахарным диабетом 2 типа //Journal of cardiorespiratory research. – 2021. – Т. 1. – №. 2. – С. 16-21.
Saito S, Teshima Y, Fukui A et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovasc Res. 2014;104(1):5–14. https://doi.org/10.1093/cvr/cvu176
Schmitt J, Duray G, Gersh B et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–1045. https://doi.org/10.1093/eurheartj/ehn579
Schnabel RB, Yin X, Gona P et al. 50-year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–162. https://doi.org/10.1016/S0140-6736(14)61774-8
Shanmugasundaram M, Paul T, Hashemzadeh M et al. Outcomes of percutaneous coronary intervention in atrial fibrillation patients presenting with acute myocardial infarction: analysis of nationwide inpatient sample database. Cardiovasc Revasc Med. 2020;21(7):851–854.
Shiga T, Wajima Z, Inoue T, et al. Magnesium prophylaxis for arrhythmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med. 2004;117:325–333.
Simmers MB, Cole BK, Ogletree ML et al. Hemodynamics associated with atrial fibrillation directly alters thrombotic potential of endothelial cells. Thromb Res. 2016;143:34–39.
Soliman EZ, Lopez F, O’Neal WT et al. Atrial fibrillation and risk of ST-segment–elevation versus non–ST-segment–elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015;131(21):1843–1850.
Steinberg JS, Zelenkofske S, Wong SC, et al. Value of P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 2017;88:2618–2622
Tanigawa M, Fukatani M, Konoe A, et al. Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrilla-tion and sinus sick node syndrome. J Am Coll Cardiol. 2018;17:403–408.
Tereshchenko LG, Rizzi P, Mewton N et al. Infiltrated atrial fat characterizes underlying atrial fibrillation substrate in patients at risk as defined by the ARIC atrial fibrillation risk score. Int J Cardiol. 2014;172(1):196–201. https://doi.org/10.1016/j.ijcard.2014.01.012
Toh N, Kanzaki H, Nakatani S et al. Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation. Hypertension. 2020;55:1150– 1156. https://doi.org/10.1161/HYPERTENSIONAHA.109.137760
van Diepen S, Siha H, Fu Y et al. Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. J Electrocardiol. 2021;43(4):351–358. https://doi. org/10.1016/j.jelectrocard.2010.04.001
Vilani GQ, Piepoli M, Cripps T, et al. Atrial late potentials in patients with paroxysmal atrial fibrillation detected using a high gain, signal-averaged esophageal lead. PACE. 2016;17:1118–1123.
Villareal R, Hariharan R, Liu B, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742–748.
Violi F, Soliman EZ, Pignatelli P et al. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc. 2016;5(5):e003347. https://doi.org/10.1161/JAHA.116.003347
Wang J, Yang YM, Zhu J. Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome. Herz. 2015;40(S1):18–26. https://doi.org/10.1007/s00059-014-4149-3
Wong CX, Sullivan T, Sun MT et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1(3):139–152. https://doi.org/10.1016/j.jacep.2015.04.004
Yamada T, Fukunami M, Shimonagata T, et al. Dispersion of signal-averaged P wave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J.2018;20:211–220.
Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol. 2019;53(3):317– 333. https://doi.org/10.1016/j.jjcc.2008.12.007
